Deal Snapshot
CANOPY BIOSCIENCES ACQUIRES CORE DIAGNOSTICS
Friday 06 December 2019

St. Louis, US-based Canopy Biosciences, LLC has acquired California, US-based CLIA-certified provider of biomarker analysis services provider Core Diagnostics, the company said.

With the acquisition of Core Diagnostics, Canopy Biosciences will be able to perform its multi-omic immune profiling services in the CLIA environment. In addition to NanoString transcriptional profiling, Core Diagnostics also offers histopathology services including immunohistochemistry and fluorescent in situ hybridisation.


TKUqg0 http://www.FyLitCl7Pf7kjQdDUOLQOuaxTXbj5iNG.com
Details
Date Published: 06/12/2019
Target: Core Diagnostics
Country: USA
Sector: Biotechnology
Type: Corporate acquisition
Financing:
Status: Closed
Vendor:
Buyer: Canopy Biosciences, LLC
Comment:
Terms of the deal were not disclosed

Options